CRL vs ULS
CRL: A global contract research organization providing non-clinical drug development services, research models, and manufacturing solutions across discovery, safety assessment, and biologics testing. ULS: UL Solutions is a premier global safety science company that provides essential testing, inspection, certification, and software services to ensure product safety, security, and sustainability.
Side-by-side fundamentals
| Metric | CRL | ULS | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $218.70 | $86.08 | |
| Market cap as of 2026-07-23 | $10.6B | $17.4B | |
| P/E as of 2026-07-23 | n/a | 49.57 | |
| PEG as of 2026-07-23 | -0.12 | 3.80 | CRL lower |
| Net margin as of 2026-07-23 | -4.6% | +11.3% | ULS higher |
| Gross margin as of 2026-07-23 | +34.5% | +49.9% | ULS higher |
| Operating margin as of 2026-07-23 | +1.8% | +17.7% | ULS higher |
| ROE as of 2026-07-23 | -5.7% | +28.8% | ULS higher |
| ROA as of 2026-07-23 | -2.5% | +12.0% | ULS higher |
| Debt / equity as of 2026-07-23 | 0.91 | 0.27 | ULS lower |
| Revenue growth (YoY) as of 2026-07-23 | +0.1% | +6.9% | ULS higher |
| Revenue CAGR (3y) SEC XBRL | +0.3% | +6.6% | ULS higher |
| Dividend yield as of 2026-07-23 | n/a | +0.6% | |
| Dividend streak (yrs) SEC XBRL | n/a | 2 | |
| Beta as of 2026-07-23 | 1.38 | 0.47 | |
| 1-year return as of 2026-07-22 close | +33.9% | +22.0% | CRL higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.